openPR Logo
Press release

Key Factor Supporting Minimal Residual Disease Testing Market Development in 2025: Rising Cancer Prevalence Fueling Growth In Minimal Residual Disease Testing Market

09-12-2025 08:40 AM CET | Health & Medicine

Press release from: The Business Research Company

Minimal Residual Disease Testing Market

Minimal Residual Disease Testing Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Minimal Residual Disease Testing Market Size By 2025?
In recent times, the market size for minimal residual disease testing has experienced fast-paced growth. The market is set to expand from a value of $1.59 billion in 2024, increasing to $1.8 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.9%. Factors such as advancements in cancer research, requirements for treatment monitoring, clinical proof, regulatory assistance, and enhancement of patient outcomes all contributed to this growth during the historic period.

How Big Is the Minimal Residual Disease Testing Market Size Expected to Grow by 2029?
In the foreseeable future, the market size for minimal residual disease testing is predicted to experience significant expansion, growth is projected to reach $2.91 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 12.8%. The predicted growth during the forecast period can be linked to factors like the rise in cancer cases, advancements in therapy, the emergence of precision medicine, a paradigm shift towards early detection, and the integration of the healthcare system. Key trends to observe during this forecast period encompass the inclusion of liquid biopsy procedures, emphasis on early relapse detection, expansion of MRD testing within clinical trials, a surge in adoption for pediatric oncology, and partnerships focused on research and development.

View the full report here:
https://www.thebusinessresearchcompany.com/report/minimal-residual-disease-testing-global-market-report

Which Key Market Drivers Powering Minimal Residual Disease Testing Market Expansion and Growth?
The rise in cancer cases is anticipated to spur the development of the minimal residual disease testing market. Cancer is a condition characterized by uncontrolled cell growth in the body, which can spread to other areas. The stages of cancer are typically identified through minimal residual disease testing, an extremely precise method for detecting cancer cells in the body. This assists cancer patients in early detection of the disease, thereby enhancing the minimal residual disease testing market. For example, in 2022, the American Cancer Society Inc., a nonprofit organization based in the US, reported that around 1.9 million new cases of cancer are likely to be diagnosed, resulting in an estimated 609,360 cancer-related deaths in the US in 2022. Thus, the escalating prevalence of cancer is fueling the expansion of the minimal residual disease testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9970&type=smp

What Are the Key Trends Driving Minimal Residual Disease Testing Market Growth?
The rise of product innovations is a significant trend being observed in the minimal residual disease testing market. Leading companies participating in this market are developing new products to maintain their market standing. For example, Twist Bioscience, a U.S. company specializing in synthetic biology and genomics, unveiled the Twist MRD Panel in 2022 to boost research and development in MRD detection for cancer screening. This panel, tailored with a selection of genes, enables the detection of exceptionally low quantities of residual cancer cells in a patient's blood. The Twist MRD Panel is highly adaptable and can fit into a standard next-generation sequencing workflow, achieving minimal residual disease detection within only five days.

What Are the Emerging Segments in the Minimal Residual Disease Testing Market?
The minimal residual disease testing market covered in this report is segmented -

1) By Test Type: DNA - Based Test, RNA- Based Test, Immunological Test
2) By Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Other Technologies
3) By Application: Hematological Malignancies, Leukemia, Lymphoma, Solid Tumors, Other Application
4) By End User: Hospitals And Specialty Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users

Subsegments:
1) By DNA-Based Test: Polymerase Chain Reaction (PCR) Tests, Next-Generation Sequencing (NGS), Digital PCR
2) By RNA-Based Test: Reverse Transcription PCR (RT-PCR), RNA Sequencing, Quantitative PCR (qPCR)
3) By Immunological Test: Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9970&type=smp

Who Are the Global Leaders in the Minimal Residual Disease Testing Market?
Major companies operating in the minimal residual disease testing market include Natera Inc., Guardant Health Inc., Laboratory Corporation of America Holdings, QIAGEN NV, F. Hoffmann-La Roche Ltd., Bio-Techne Corporation, Bio-Rad Laboratories Inc., Sysmex Corporation, Exact Sciences Corporation, GRAIL LLC, Veracyte Inc., Cergentis B.V, Mdxhealth SA, NeoGenomics Laboratories Inc., Adaptive Biotechnologies, OPKO Health Inc., Thermo Fisher Scientific Inc., Siemens Healthineers AG, PerkinElmer Inc., Agilent Technologies Inc., ArcherDx Inc., Asuragen Inc., Becton, dic*kinson and Company, Cepheid Inc., Fluidigm Corporation, Illumina Inc., Invitae Corporation, Janssen Diagnostics LLC, Luminex Corporation, Menarini Silicon Biosystems S.p.A.

Which are the Top Profitable Regional Markets for the Minimal Residual Disease Testing Industry?
North America was the largest region in the minimal residual disease testing market in 2024. The regions covered in the minimal residual disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9970

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Key Factor Supporting Minimal Residual Disease Testing Market Development in 2025: Rising Cancer Prevalence Fueling Growth In Minimal Residual Disease Testing Market here

News-ID: 4180364 • Views:

More Releases from The Business Research Company

Asthma Drugs Market Growth Accelerates: Strategic Forecast Predicts $31.38 Billion by 2029
Asthma Drugs Market Growth Accelerates: Strategic Forecast Predicts $31.38 Billi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Asthma Drugs Industry Market Size Be by 2025? In the past few years, the longevity of the asthma medications market has been systematically expanding. This market, which worth $23.96 billion in 2024, will surge to $24.93 billion in 2025, registering a compound annual growth rate (CAGR)
Soaring Demand Set to Propel Multiple Myeloma Drugs Market to $29.44 Billion by 2029
Soaring Demand Set to Propel Multiple Myeloma Drugs Market to $29.44 Billion by …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Multiple Myeloma Drugs Market Through 2025? The market for multiple myeloma drugs has seen significant growth in recent times. The market is projected to increase from $21.84 billion in 2024 to $23.03 billion in 2025, experiencing a compound annual growth rate (CAGR)
Lactose Intolerance Treatment Market Expansion Continues, with Forecast Valuation of $45.74 Billion by 2029
Lactose Intolerance Treatment Market Expansion Continues, with Forecast Valuatio …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Lactose Intolerance Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for lactose intolerance treatment has witnessed robust growth in the past few years. The market, which was valued at $32.4 billion in 2024, is projected to rise to $34.43 billion in
Emerging Trends to Reshape the Anti-Aging Drugs Market: Product Innovations Skinceuticals' A.G.E Interrupter Advanced Driving Anti-Aging Drug Market as a Key Influencer
Emerging Trends to Reshape the Anti-Aging Drugs Market: Product Innovations Skin …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Anti-Aging Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In the past few years, the anti-aging drugs market has experienced substantial growth. The market is projected to increase from a value of $57.18 billion in 2024 to $60.81 billion in 2025, growing at a

All 5 Releases


More Releases for Test

Vitamin Test Market: Global Vitamin Test Analysis and Forecast (2023-2029)Vitami …
12.04.2024: Vitamin Test Market Overview The development of companion diagnostic tools and advances in personalised treatment are driving considerable growth and revolution in the oncology Vitamin Test market. In the era of precision medicine, where healthcare is increasingly customised for individual individuals based on their own genetic and molecular profiles, this market segment is essential. Ongoing innovation and development define the oncology Vitamin Test market. To find particular biomarkers, genetic mutations,
CAGR 8.1% Homecare Pregnancy Test Kits Market By Type of Test (Urine Test For H …
The Homecare Pregnancy Test Kits market report by Reports and Data provides an extensive overview of the vital elements of the Homecare Pregnancy Test Kits market and factors such as the drivers, restraints, latest trends, supervisory scenario, competitive landscape, technological advancements, and others. Further, it mentions the market shares associated with the market in terms of both value and volume along with the segmentation. Space-age industrial and digitalization tools are
Home Safety Test Kits Market, Home Safety Test Kits Market Trends, Home Safety T …
“Home Safety Test Kits Market” 2020-2025 Research Report is a professional and in-depth study on the current state of the market. Global Home Safety Test Kits market containing a complete view of the market size, business share, profit estimates, SWOT analysis and the regional landscape of the Industry. The report explains key challenges and future development prospects of the market. The Global Home Safety Test Kits analysis is provided for
Test Data Management (TDM) Market - test data profiling, test data planning, tes …
The report categorizes the global Test Data Management (TDM) market by top players/brands, region, type, end user, market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. This report studies the global market size of Test Data Management (TDM) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption
Hearing Screening and Diagnostic Devices Market Demands with Major Tests: pure T …
New Market Research Reports Title "Hearing Screening And Diagnostic Devices Market 2018" Has Been Added to Crystal Market Research Report database. Hearing Screening and Diagnostic Devices - Competitive Insights: The leading players in the market are Gn Otometrics A/S, Otodynamics, Nashua Hearing Group, Siemens Healthineers, Natus Medical Incorporated, Interacoustics A/S, Neurosoft S.A, Accent Hearing Pty Ltd, MAICO Diagnostics GmbH and IntriCon Corporation. The major players in the market are profiled in detail
Global Low Temperature Test Equipment Market Outlook 2017 : Ektron Tek, IEC Test …
Global Low Temperature Test Equipment Market 2017-2022 A market study ” Global Low Temperature Test Equipment Market ” examines the performance of the Low Temperature Test Equipment market 2017. It encloses an in-depth Research of the Low Temperature Test Equipment market state and the competitive landscape globally. This report analyzes the potential of Low Temperature Test Equipment market in the present and the future prospects from various angles in detail. The Global